Dengue: Takeda’s vaccine is approved in Brazil
The granting of the registration by Anvisa allows the commercialization of the product in the country, as long as the approved conditions are maintained
10/04/2023
The granting of the registration by Anvisa allows the commercialization of the product in the country, as long as the approved conditions are maintained
10/04/2023If proven effective in clinical trials, the candidate vaccines will be additional control tools to reverse the advancement of tuberculosis
10/04/2023Exposure to the pathogen triggered adaptation mechanisms that, more than seven millennia ago, ended up selecting a gene that confers resistance to the disease
10/04/2023Illegal mining causes malaria outbreak among indigenous people in the Amazon
10/04/2023